Market Study Report recently added a new title on 2021-2027 Global Cystic Fibrosis Therapeutics Market Report from its database. The report provides study with in-depth overview, describing about the Product, Size, Share, Industry Scope and elaborates market outlook and status to 2027.

Cystic fibrosis (CF) is a genetic condition that makes patients susceptible to recurrent and chronic lung infections. In patients suffering from cystic fibrosis, the CFTR protein becomes dysfunctional as a result of mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This condition causes glands to produce mucus and sweat that is sticky and thick, thereby clogging airways and damaging organs.

Request a Sample Report of Cystic Fibrosis Therapeutics Market at: https://www.marketstudyreport.com/request-a-sample/4357556/?utm_source=Marketwatch.com/&utm_medium=SP

The cystic fibrosis therapeutics market is projected to observe substantial growth by 2027 owing to surging focus on the discovery and development of novel treatment therapies around the world.

The ongoing COVID-19 outbreak has necessitated the development of innovative therapies for the treatment of various types of lung infections and diseases. As a result, multiple scientific investigations undertaken by medical laboratories have facilitated market expansion in key regions across the globe.

The cystic fibrosis therapeutics market has been segmented on the basis of distribution channel, treatment method, and region. In terms of treatment method, the market has further been categorized into devices, medications, and others.

Notably, prominent industry participants are employing lucrative business tactics to monetize favorable market trends by introducing new products, building strategic partnerships, and acquisitions, which have enhanced overall market dynamics. For instance, in March 2021, Pharmaxis Ltd., an Australian pharmaceutical company, announced that its cystic fibrosis treatment, Bronchitol, had been launched in the U.S. by Chiesi USA, Ltd., a leading pharmaceutical firm. Pharmaxis received a total payment of USD 10 million for the stock of Bronchitol that is being commercialized in the United States by Chiesi.

In another instance, in July 2021, biopharmaceutical giant AstraZeneca completed the acquisition of Alexion Pharmaceuticals, Inc., a global biopharmaceutical company. Through the acquisition, AstraZeneca improved scientific discoveries and developed suitable medications for people with rare diseases using Alexion’s strong pipeline and innovative complement-biology platform.

The devices sub-segment held a market share of around 9% in 2020 and is expected to grow at a steady pace over 2021-2027. Soaring demand for devices used to cure cystic fibrosis is likely to drive segmental growth in the forthcoming years.

With respect to distribution channel, the cystic fibrosis therapeutics market has been bifurcated into retail pharmacies, hospitals, and others. In 2020, the retail pharmacies sub-segment accounted for nearly 35% market share and is slated to observe optimistic growth over the forecast timeline. Mounting prevalence of retail pharmacies in developed economies is slated to bolster segmental adoption over the following years.

Some of the prominent companies operating in the market are Vertex Pharmaceutical Incorporated, Roche, Nestle Health Science, AbbVie, Viatris Inc., Gilead Sciences, Chiesi Farmacrutici, and Teva Pharmaceuticals.

From the regional point of view, the North America cystic fibrosis therapeutics market attained a valuation of more than USD 6 billion in 2020 and is estimated to amass considerable gains by the end of 2027. Growing number of CF patients in the region is set to drive market expansion through the review period.

For More Details on Cystic Fibrosis Therapeutics Market Report at: https://www.marketstudyreport.com/reports/cystic-fibrosis-therapeutics-market?utm_source=Marketwatch.com/&utm_medium=SP

About Us:

Market Study Report is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report is the platform that can help you in achieving any of these objectives.

Contact Us:

Corporate Sales,

Market Study Report

Phone: 1-302-273-0910

Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

News: https://www.nwdiamondnotes.com/

Leave a comment

Your email address will not be published. Required fields are marked *